The panelists, Jorge Cortes, MD; Javier Pinilla-Ibarz, MD, PhD; David Snyder, MD, FACP; and Harry Erba, MD, PhD, share perspectives on clinical scenarios in chronic myeloid leukemia that may prompt a treatment change.

Panelists discuss approaches to selecting a first-line tyrosine kinase inhibitor for initial therapy in patients with newly diagnosed chronic myeloid leukemia.

Every year, approximately 20 to 30 new cases of Chronic Myeloid Leukemia is being diagnosed in Singapore (Cancer Registry Report 2015). Mdm Kaliammal is one of them. This is her story.

MD Anderson researchers play crucial role in two New England Journal of Medicine studies showing newer drugs for chronic myeloid leukemia work faster and better than imatinib (Gleevec®).

Dr. Rahul Bhargava, Principal Director, Hematology, Hemato-oncology & BMT FMRI, Gurugram, talks about Chronic Myeloid Leukemia (CML)—a blood cancer that affects the white blood cells and tends to progress slowly over many years and how simple blood tests like CBC and BCR-ABL Quantitative IS can help in diagnosing the condition early.

This CML Awareness Month, get yourself tested with SRL Diagnostics if you're seeing symptoms of the disease.

The panelists, Javier Pinilla-Ibarz, MD, PhD; Harry Erba, MD, PhD; Jorge Cortes, MD; and David Snyder, MD, FACP, elaborate on the practice of bone marrow assessments in the management of chronic myeloid leukemia.